Viewing data from:

MARAVIROC

ANDA

MARAVIROC | A203347 | HETERO LABS LTD UNIT III

2 strengths0 unique patents0 unique exclusivities

Reference Listed Drug: SELZENTRY(TE code: AB)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 2 NDCs

Highest NADAC/Unit

$9.15

per ea

Lowest NADAC/Unit

$7.06

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
31722057960MARAVIROC 150 MG TABLET	$9.15	EA	Generic	—	2025-11-19
31722058060MARAVIROC 300 MG TABLET	$7.06	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

VA Federal Supply Schedule

Government-negotiated contract prices | 2 NDCs (2 FSS)

Lowest Price

$849.10

Highest Price

$849.10

FSS NDCs

Big4 NDCs

Description	Price	Type	Vendor	Contract End
72865-0231-60MARAVIROC 150MG TAB	$849.10	FSS	XLCare Pharmaceuticals, Inc.	05/31/2026
72865-0232-60MARAVIROC 300MG TAB	$849.10	FSS	XLCare Pharmaceuticals, Inc.	05/31/2026

Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.

API Supply Chain5 active DMFs

4 active API suppliers hold Drug Master Files for this ingredient.

HETERO LABS LTDMARAVIROC (FORM-B)

DMF 251152011

HETERO LABS LTDMARAVIROC AMORPHOUS

DMF 251212011

CAMBREX PROFARMACO MILANO SRLMARAVIROC

DMF 341822020

COHANCE LIFESCIENCES LTDMARAVIROC

DMF 357892021

NAVINTA LLCMARAVIROC

DMF 369172022

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Aug 4, 2022	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (2)

Sort:

#001 — 150MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Feb 7, 2022

No patent or exclusivity listings for this strength.

#002 — 300MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Feb 7, 2022